Charles River Laboratories (CRL) Tops Q1 EPS by 25c; raises guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- Nasdaq ends higher as AI heavyweights rebound ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts CRL Hot Sheet
Price: $351.87 +3.94%
EPS Growth %: +22.2%
Financial Fact:
Interest income: 523K
Today's EPS Names:
FUSE, INM, TRI, More
EPS Growth %: +22.2%
Financial Fact:
Interest income: 523K
Today's EPS Names:
FUSE, INM, TRI, More
Join SI Premium – FREE
Charles River Laboratories (NYSE: CRL) reported Q1 EPS of $2.34, $0.25 better than the analyst estimate of $2.09. Revenue for the quarter came in at $984.2 million versus the consensus estimate of $941.47 million.
GUIDANCE:
Charles River Laboratories sees FY2025 EPS of $9.30-$9.80, versus the consensus of $9.31.
For earnings history and earnings-related data on Charles River Laboratories (CRL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JELD-WEN Holding, Inc. (JELD) Tops Q3 EPS by 1c, Misses on Revenue; Offers FY26 Revenue Guidance
- EagleRock Land, LLC (EROK) Reports Q3 EPS of $0.08
- Modine Manufacturing (MOD) Misses Q2 EPS by 7c; offers guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
